Sputum exosomes: promising biomarkers for idiopathic pulmonary fibrosis.
Where this comes from
- Record sourced from PubMed, PMID 30244194.
- Also identified by DOI 10.1136/thoraxjnl-2018-211897 and PMC identifier 6467246.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung disease of unknown aetiology which leads rapidly to death. As diagnosis of IPF is complex, we aimed to characterise microRNA (miRNA) content of exosomes from sputum of patients with IPF. Using miRNA quantitative PCR array, we found a substantial dysregulation of sputum exosomal miRNA levels between patients with IPF and healthy subjects and identified a unique signature of three miRNAs. Interestingly, we found a negative correlation between miR-142-3p and diffusing capacity of the lungs for carbon monoxide/alveolar volume. This is the first characterisation of miRNA content of sputum-derived exosomes in IPF that identified promising biomarkers for diagnosis and disease severity.
Medical subject headings
- Exosomes
- Idiopathic Pulmonary Fibrosis
- MicroRNAs
- Sputum